We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

PFO ACCESS Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00583401
Recruitment Status : No longer available
First Posted : December 31, 2007
Last Update Posted : February 20, 2018
Sponsor:
Information provided by (Responsible Party):
St. Jude Medical

December 21, 2007
December 31, 2007
February 20, 2018
 
PFO ACCESS Registry
Closure of Patent Foramen Ovale with the AMPLATZER® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy.
The primary objective of the PFO Access Registry is to allow access to the AMPLATZER PFO Occluder in subjects with a PFO who have already experienced at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional drug therapy.
Expanded Access
Device: Device closure with the AMPLATZER PFO Occluder
Device closure with the AMPLATZER PFO Occluder
Not Provided
 
No longer available
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00583401
St. Jude Medical
St. Jude Medical
Not Provided
Not Provided
St. Jude Medical
February 2018